Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Completed 1Active not recruiting 1

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 2Dermatologic 2Other solid neoplasm 1Myeloid 1Lymphoid 1

Conditions

Carcinoma, Non-Small-Cell Lung 607Lung Neoplasms 190Mesothelioma, Malignant 46Adenocarcinoma of Lung 42Mesothelioma 40Neoplasms 31Neoplasm Metastasis 28Carcinoma 18Colorectal Neoplasms 16Small Cell Lung Carcinoma 14Parkinson Disease 4, Autosomal Dominant Lewy Body 14NSCLC 14Adenocarcinoma 11Melanoma 10Lung Diseases 10Brain Neoplasms 10Adenocarcinoma, Bronchiolo-Alveolar 9Thoracic Neoplasms 8Non-squamous Non-small Cell Lung Cancer 8Carcinoma, Bronchogenic 8Respiratory Tract Neoplasms 7Non-Squamous Non-Small Cell Lung Cancer 7Neoplasms by Site 7Bronchial Neoplasms 7Respiratory Tract Diseases 6Ovarian Neoplasms 6Neoplasms by Histologic Type 6Meningeal Carcinomatosis 6Squamous Cell Carcinoma of Head and Neck 5Solitary Fibrous Tumor, Pleural 5

Interventions

pembrolizumab 4Nivolumab 3Specimen Handling 2Pemetrexed 2Magnetic Resonance Spectroscopy 2Cyclophosphamide 2utomilumab 1tislelizumab 1spartalizumab 1ruxolitinib 1pentetreotide 1niraparib 1montanide ISA 51 1fludarabine phosphate 1entinostat 1avelumab 1Valacyclovir 1Toll-Like Receptor 1 1Spinal Puncture 1Rose Bengal 1Radiosurgery 1LY2940680 1Interleukin-2 1Interleukin-13 1Injections 1Immunologic Techniques 1Fluorodeoxyglucose F18 1Cryosurgery 1Cisplatin 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Uveal Melanoma × Pemetrexed × Thoracic × Clear all
NCT04328844 2026-03-30

A Study to Assess a PI3Kδ Inhibitor (IOA-244) in Patients With Metastatic Cancers

iOnctura

Phase 1 Active not recruiting
210 enrolled
DermatologicLymphoidMyeloidOther solid neoplasmThoracic

Uveal Melanoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Melanoma, Mesothelioma, Primary Myelofibrosis

NCT04993677 2025-05-11

A Study of SEA-CD40 Given With Other Drugs in Cancers

Seagen Inc.

Phase 2 Completed
77 enrolled 18 charts
DermatologicThoracic

Uveal Melanoma, Carcinoma, Non-Small-Cell Lung, Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡